Early treatment with vamorolone shows sustained efficacy and improved safety profile More: Santhera reports promising long-term data for AGAMREE in Duchenne muscular dystrophy Source: News
read moreQuestex has acquired The Conference Forum and Versalinx Global Events, two highly respected organizers known for convening the leaders shaping clinical innovation, competitive intelligence, market research and the future of drug delivery. More: Publisher’s note: Questex acquisition supercharges Fierce portfolio
read moreEli Lilly is going for gold at the Milano Cortina 2026 Olympic and Paralympic Winter Games. More: Lilly signs on as 2026 Milan Olympics sponsor, re-ups donations for each Team USA win Source: fierce
read moreUCB has scored an FDA approval for ultra-rare disease treatment Kygevvi, continuing the positive momentum for the Belgian company, which has scored three nods in the U.S. for rare disease treatments in less than three years. More: On a roll,
read moreKimberly-Clark has placed an ambitious bet on a troubled counterpart, agreeing to buy out Johnson & Johnson’s consumer health spinout Kenvue for $48.7 billion. More: Kimberly-Clark buys out Kenvue in .7B consumer health merger Source: fierce
read moreNeurology-focused patient groups’ perception of the pharma industry’s corporate reputation remains on a downward slope. More: Pharma’s corporate reputation dips among neurology patient groups, citing drug access challenges Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals